Physician profile
Christopher Le
NPI 1679700801
$4,526.71
in general payments reported to CMS, 2019-2025
10 companies · $3,180 in 2025
The $3,180 reported for 2025 was more than what 94% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $93.22 · 2021: $86.80 · 2022: $281 · 2023: $608 · 2024: $47.12 · 2025: $3,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Travel and Lodging: $1,176 · Food and Beverage: $1,160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $1,175.76 |
| Food and Beverage | $1,159.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $2,823.23 | 2025 | |
| Stryker Corporation | $334.29 | 2022-2023 | Focess Hd Wireless Camera |
| Genzyme Corporation | $309.49 | 2023-2025 | |
| Medtronic, INC. | $306.44 | 2021-2024 | Stealthstation S8 Platform |
| Medtronic USA, INC. | $206.77 | 2019-2020 | |
| Neurent Medical Limited | $152.06 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Mentor Worldwide LLC | $147.32 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Arrinex, INC. | $117.14 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $99.97 | 2023 | Dupixent |
| Averitas Pharma INC. | $30.00 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.